SeraCare Life Sciences has expanded its suite of clinical genomics development, validation, and quality control tools with the launch of the Seraseq breast copy number variation (CNV) mix and Seraseq lung and brain CNV mix.
Read MoreThermo Fisher Scientific has expanded its Oncomine portfolio with new assays for liquid biopsy and immunooncology.
Read More
Presenting an evaluation of the GeneReader next-generation sequencing (NGS) system, the article assesses the performance of the system in comparison with an alternative NGS technology.
Read More
An expert review from the American Society of Clinical Oncology and the College of American Pathologists has provided an assessment of current evidence about the use of liquid biopsy tests in oncology.
Read More
Key medical societies are offering new standards for the molecular testing of lung cancers to guide targeted therapies.
Read More